Cui HaiHong, Huang JinCheng
Yanhe Tujia Autonomous County People's Hospital, Guizhou Province, China.
SSL Central Hospital of Dongguan City, Guangdong Province, China.
Int J Surg Case Rep. 2023 Sep;110:108772. doi: 10.1016/j.ijscr.2023.108772. Epub 2023 Sep 1.
The report on Levonorgestrel⁃releasing intrauterine system (LNG⁃IUS) suture under hysteroscopy is very rare, and currently only three articles have been reported. We reported a patient with adenomyosis who had previously had LNG-IUS, but the LNG-IUS moved downward. We sutured and fixed the LNG-IUS under hysteroscopy.
A 42-year-old woman presented with a 7-year history of adenomyosis of the uterus and adenomyoma adenomyosis. Half a year ago, due to increased menstrual flow, LNG-IUS was placed in the uterine cavity, and the treatment effect was satisfactory. Nine days ago, vaginal bleeding occurred, and ultrasound showed that LNG-IUS had moved downward. We performed LNG-IUS suturing under hysteroscopy for her, and a half-year follow-up ultrasound showed that the position of LNG-IUS was normal.
For adenomyosis, LNG-IUS is the most promising medical therapy due to its ability to suppress hormones to improve symptoms with a low profile of adverse effects while enabling women to maintain fertility. However, the high excretion rate of LNG-IUS may cause patients with adenomyosis to lose confidence in continuing to use this treatment method.
Our case report demonstrated the feasibility and effectiveness of LNG-IUS suture fixation under hysteroscopy. It provided another reliable treatment option for those patients with adenomyosis for whom the LNG-IUS fell off or fell down.
关于宫腔镜下左炔诺孕酮宫内节育系统(LNG-IUS)缝合的报道非常罕见,目前仅有三篇文章报道过。我们报告了一名患有子宫腺肌病的患者,该患者此前放置过LNG-IUS,但LNG-IUS向下移位。我们在宫腔镜下对LNG-IUS进行了缝合固定。
一名42岁女性,有7年子宫腺肌病和腺肌瘤性子宫腺肌病病史。半年前,因月经量增多,在宫腔内放置了LNG-IUS,治疗效果满意。九天前,出现阴道出血,超声显示LNG-IUS向下移位。我们为她在宫腔镜下进行了LNG-IUS缝合,半年后的超声随访显示LNG-IUS位置正常。
对于子宫腺肌病,LNG-IUS是最有前景的药物治疗方法,因为它能够抑制激素以改善症状,副作用较小,同时能使女性维持生育能力。然而,LNG-IUS的高排出率可能会使子宫腺肌病患者对继续使用这种治疗方法失去信心。
我们的病例报告证明了宫腔镜下LNG-IUS缝合固定的可行性和有效性。它为那些LNG-IUS脱落或下移的子宫腺肌病患者提供了另一种可靠的治疗选择。